Improving Addiction Care Team (IMPACT): OHSU Pharmacy and Therapeutics Policy on use of Medication to Treat Opioid Use Disorder (Pregnant and Non-Pregnant Patients)

Source: Dr. Honora Englander

This resource is Oregon Health & Science University’s pharmacy and therapeutics policy on the use of medications (methadone, buprenorphine, and naltrexone) for opioid withdrawal management or opioid maintenance therapy in patients with opioid use disorder who are hospitalized or seen in the emergency department. The document describes the hospitals procedures for patients who present to the emergency department or labor and delivery for a missed medication dose, patients who are treated in the hospital who are on maintenance medication therapy, on patients seeking treatment of withdrawal or induction to maintenance therapy. This policy was included as one of the protocols and tools for Oregon Health & Science University’s Improving Addiction Care Team (IMPACT) program which provides addiction medicine consultations to patients treated in the hospital who have a diagnosis of substance use disorder.

Funding Source: Oregon Health & Science University

513.5 KB

mproving Addiction Care Team (IMPACT): OHSU Pharmacy and Therapeutics Policy on use of Medication to Treat Opioid Use Disorder (Pregnant and Non-Pregnant Patients)

The Oregon Health & Science University pharmacy and therapeutics policy on the use of medications for opioid withdrawal management or opioid maintenance therapy